Injectables market opening up to China

Schott Pharmaceutical Packaging will be the first international manufacturer of primary pharmaceutical glass packaging to establish a production site in China, in a move that will increase supply to Chinese injectable drug manufacturers hungry to compete on the world stage.

The facility will produce Schott Type I borosilicate glass, a high quality tubing glass that complies with international standards USP, EP and JP and manufacturing will begin in China by mid 2006.
This type of glass, used to make vials and syringes for the pharmaceutical industry, has seen a strong increase in demand at the top end of the market in China, as manufacturers there are increasingly gaining access to more high quality medications that require high standard glass delivery devices.

“Previously supply of this glass was limited in China and many drug manufacturers had to import it if they wanted to export their products to countries that demand glass packaging that meets international standards,” a company spokesman told

Glass is very inert and many plastic forms of packaging are not suitable as drug delivery devices for certain types of drugs because they can cause an ion exchange.

This plant will give Chinese manufacturers greater access to the product through shorter production and delivery times, opening up the door of opportunity for Chinese companies to not only distribute high quality injectables more widely in China, but export outside of China and compete with drug companies who currently supply lucrative markets such as Europe and the US.

The injectable drug market is growing strongly at present, driven by the rising number of biologic drugs coming though the biopharma industry's pipelines, as most therapeutic protein drugs must be administered by injection.

Rising 16.3 per cent to an estimated $83 billion (€70.2 billion) in 2002, the injectable drug delivery industry is forecast to grow at a CAGR of 10 per cent between 2002 and 2008.

Western injectable drug makers will now have to keep an eye on Chinese companies beginning to muscle in on their territory.

“We are expecting the market for Schott Type I borosilicate glass to continue to grow in China and we think our company will grow faster than the market,” the company said.

Currently Schott is dominant in the Chinese market for this type of glass, with a 50 per cent market share, and only a handful of small Chinese manufacturers as competitors.

It is expected that Schott's main competitors, Beckton Dickinson, Gerresheimer and Nuovo Ompi will soon follow into China to grab a slice of the action.

600450 Injectables market opening up to China

See more news about:

Others also read

Emirates Glass, a Dubai Investment subsidiary, has won a major contract to supply 140,000 square meters of its premium glass to the prestigious development on the Palm Jumeirah, reaffirming its already established reputation as the single most prominent company in the entire regional glass industry.The deal was announced during the company's participation in the prestigious Big 5 show, the largest annual venue for the entire Middle-East glass contracting industry.
Isra Vision Systems AG supplier of machine vision systems, has successfully improved its market position in display glass inspection with a major order totalling 1.8 Mio Euro.
Packagers such as the UK's Rexam and private equity firms are set to vie for pump-sprayer business Calmar, which France's Saint-Gobain (SGOB.
Jain Scientific Glass Works, manufacturers of glassware for laboratories, is importing glass as raw material from China, which was much cheaper than the local product and abundantly available.
The National Lime & Stone Co. will discontinue production of calcined lime early next month at its Carey plant, the company CEO announced Thursday.
The following stocks are moving in Japanese markets today. Prices are as of 12:55 p.m. at the Tokyo Stock Exchange. Stock symbols are in parentheses after company names.

Add new comment